CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 72 filers reported holding CATALYST BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,874,000 | -5.1% | 1,429,242 | 0.0% | 1.75% | +5.2% |
| Q2 2021 | $6,189,000 | +58.4% | 1,429,242 | +84.4% | 1.66% | +38.1% |
| Q1 2021 | $3,907,000 | -19.8% | 775,274 | +0.4% | 1.20% | -31.0% |
| Q4 2020 | $4,873,000 | +46.7% | 772,314 | 0.0% | 1.74% | +3.6% |
| Q3 2020 | $3,321,000 | -23.1% | 772,314 | +5.0% | 1.68% | -28.1% |
| Q2 2020 | $4,319,000 | +34.3% | 735,841 | 0.0% | 2.34% | -6.4% |
| Q1 2020 | $3,216,000 | -35.8% | 735,841 | 0.0% | 2.50% | -56.0% |
| Q4 2019 | $5,011,000 | +38.7% | 735,841 | 0.0% | 5.69% | +19.4% |
| Q3 2019 | $3,613,000 | +78.3% | 735,841 | +167.6% | 4.77% | +117.3% |
| Q2 2019 | $2,026,000 | +75.4% | 274,936 | +93.0% | 2.19% | +172.9% |
| Q1 2019 | $1,155,000 | +2.8% | 142,451 | 0.0% | 0.80% | +14.7% |
| Q4 2018 | $1,124,000 | – | 142,451 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |